
X
AZ’s cancer and respiratory drugs approved in Japan
https://pharmaphorum.com/news/azs-cancer-respiratory-drugs-approved-japan/
NICE calls for further discounts on beta-interferons and Copaxone
IL-5 drug approved in EGPA
Erenumab under review in US and EU
R&D chief Michael Hayden to leave at year end.
GSK looks to build on mepolizumab’s success in asthma
Federal court throws out patents on Restasis